Reports ◆ library
Reports · 报告库
Start here
Flagship · BsAb-MR-2026Q3
Bispecific Antibody Market Report
Intelligence-led deep-dive on the bispecific antibody market: pipeline census, TCE analysis, target pairs, autoimmune & other therapeutic areas, deals, failures and tool-demand mapping.
12 chaptersEvidence cutoff · 2026-08-19
Weekly brief · liveEvent Intelligence & Weekly Briefs
Weekly event intelligence across the Golden Pairs — source-linked, evidence-graded, mapped to demand signals.
Open access
Quarterly Market Report
The flagship census: 538 trials, TCE cluster analysis, target pairs, deals, failures and tool-demand mapping. Quarterly rerun.Quarterly Market Report
Executive Summary — Three Judgments
Open
Quarterly Market ReportMarket Overview — 538-Trial Census by TA
Open
Quarterly Market ReportMarket Size — Scenarios to 2030E
Open
Quarterly Market ReportTechnology Landscape — Formats Decide the Reagent Stack
Open
Quarterly Market ReportTCE Deep Dive — CD3ε Standard Arm and Reagent Gaps
Open
Quarterly Market ReportTarget Pairs — Five Golden Pairs, Scored
Open
Quarterly Market ReportAutoimmune & Other TAs — Observation Sector
Open
Quarterly Market ReportClinical Pipeline — Readout Calendar and the Phase 2 Squeeze
Open
Quarterly Market ReportDeals & Financing — Where the Money Went
Open
Quarterly Market ReportFailures & Competition — Approval Is Not Winning
Open
Quarterly Market ReportTools & Services — Commodity 6, Differentiated 1, White Space 1
Open
Quarterly Market ReportMethodology & Evidence Ledger
Open
Weekly Intelligence Brief
Weekly event intelligence across the Golden Pairs — source-linked, evidence-graded, mapped to demand signals.About this library
Every report is intelligence-led: figures are source-linked, evidence-graded where public, and mapped to the research tools and services each decision requires. The flagship census reruns quarterly; weekly briefs update every Monday.